Resistance to thyroid hormone associated with autoimmune thyroid disease in a Turkish family

被引:0
作者
D. Y. Aksoy
A. Gurlek
U. Ringkananont
R. E. Weiss
S. Refetoff
机构
[1] Hacettepe University,Section of Endocrinology and Metabolism, Department of Internal Medicine
[2] Medical Faculty,Department of Medicine
[3] The University of Chicago,Departments of Medicine and Committee on Molecular Medicine
[4] The University of Chicago,Departments of Medicine and Pediatrics and Committees on Genetics and Molecular Medicine
[5] The University of Chicago,undefined
来源
Journal of Endocrinological Investigation | 2005年 / 28卷
关键词
Autoimmune thyroiditis; resistance to thyroid hormone; mutation; thyroid hormone receptor;
D O I
暂无
中图分类号
学科分类号
摘要
The syndrome of resistance to thyroid hormone (RTH) is characterized by impaired tissue responses to thyroid hormone. Hashimoto’s thyroiditis is the most common thyroid autoimmune disease. We present a Turkish family with both RTH and Hashimoto’s thyroiditis. RTH was detected through the presence of point mutation in thyroid hormone receptor (TR), and Hashimoto’s thyroiditis was diagnosed due to the presence of thyroid autoantibodies. The proposita, her affected mother as well as her unaffected sister have thyroid autoantibodies consistent with Hashimoto’s thyroiditis, and a heterozygous point mutation in exon 10 encoding the ligand (3,3′,5-L-T3)-binding domain of the TRβ gene was detected in both the proposita and the mother. The mutation is a replacement of cytosine for guanine in codon 453 (CCT->GCT) producing a missense mutation substituting a normal proline with an alanine (P453A), which reduces the affinity for T3 to 17% of that of the normal TRβ. Both also have modest elevation of serum TSH levels. In severe RTH, marked elevation of thyroid hormone concentrations in the absence of suppressed TSH supports the laboratory diagnosis of RTH. However, when RTH is mild and associated with thyroiditis, even a modest thyroid gland insufficiency can obliterate the serum T4 and T3 elevations, typical of RTH. This will manifest as elevated serum TSH. Demonstration of TRβ gene mutation is then necessary to establish the diagnosis. In addition, under these circumstances, treatment with thyroid hormone should be considered.
引用
收藏
页码:379 / 383
页数:4
相关论文
共 83 条
[1]  
Beck-Peccoz P(1994)The variable clinical phenotype in thyroid hormone resistance syndrome Thyroid 4 225-32
[2]  
Chatterjee VKK(1995)Genetic and clinical features of 42 kindreds with resistance to thyroid hormone The National Institutes of Health prospective study. Ann Intern Med 123 573-83
[3]  
Brucker-Davis F(1993)The syndromes of resistance to thyroid hormone Endocr Rev 14 348-99
[4]  
Skarulis MC(1995)Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-β receptors? J Clin Endocrinol Metab 80 3246-56
[5]  
Grace MB(1993)An arginine to histidine mutation in codon 311 of the C-erbAβ gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype J Clin Invest 91 538-46
[6]  
Refetoff S(1993)Identical mutations inunrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene: Analysis of 15 families J Clin Invest 91 2408-15
[7]  
Weiss RE(1997)Phenotype differences of resistance to thyroid hormone (RTH) in two unrelated families with identical mutations in the thyroid hormone receptor β gene (R320C) Thyroid 7 35-8
[8]  
Usala SJ(1993)Multiple genetic factors in the heterogeneity of thyroid hormone resistance J Clin Endocrinol Metab 76 257-9
[9]  
Hayashi Y(1994)Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone: identification of thirteen novel mutations in the thyroid hormone receptor β gene J Clin Invest 94 506-15
[10]  
Weiss RE(2001)Identification of eight new mutations in the c-erbAB gene of patients with resistance to thyroid hormone Ann Endocrinol (Paris) 62 220-5